Frazier Lifesciences Acquisition Corporation

Informe acción NasdaqCM:FLAC

Capitalización de mercado: US$183.7m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Salud financiera de hoja de balance de Frazier Lifesciences Acquisition

Salud financiera controles de criterios 3/6

Información clave

n/a

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$375.55k
Patrimonio-US$11.67m
Total pasivoUS$150.95m
Activos totalesUS$139.28m

Actualizaciones recientes sobre salud financiera

Recent updates

Frazier Lifesciences SPAC said in talks to take NewAmsterdam Pharma public

Jul 19

Análisis de la situación financiera

Pasivos a corto plazo: FLAC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Pasivo a largo plazo: FLAC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Historial y análisis de deuda-patrimonio

Nivel de deuda: FLAC is debt free.

Reducción de la deuda: FLAC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Cobertura de la deuda: FLAC has no debt, therefore it does not need to be covered by operating cash flow.

Cobertura de intereses: FLAC has no debt, therefore coverage of interest payments is not a concern.


Hoja de balance


Descubre empresas con salud financiera